On December 11, 2024, a bill was introduced in the U.S. House of Representatives that, if enacted, would have substantial implications for ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

PBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...

CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...

CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

CVS's stock has gained hiked up 22.5% so far this year, after plunging 43.2% in 2024 to suffer its worst year since 2001. In comparison, the S&P 500 has tacked on 3.2% year to date after rallying 23.3 ...

We recently caught up with Nick Karls, director of compliance at Holmes Murphy and Associates, and Nathan Cassin, pharmacy ...

Sen. Scott Wiener (D-San Francisco) has introduced two bills in the State Senate that could lower prescription drug prices ...

A bill to stop Pharmacy Benefit Managers or PBMs from giving pharmacies less money than it costs to fill prescriptions advanced through the Iowa House Commerce Committee Tuesday.

Ken Paxton's opinion puts Texas on a collision course with employer groups that say ERISA should shield the plans from the ...